LONG-TERM SURVIVAL IN PATIENTS RESPONDING TO ANTI-PD-1/PD-L1 THERAPY AND DISEASE OUTCOME UPON TREATMENT DISCONTINUATION. Gauci, M. L.; Lanoy, E.; Champiat, S.; Caramella, C.; Ammari, S.; Aspeslagh, S.; Varga, A.; Baldini, C.; Bahleda, R.; Gazzah, A.; Michot, J. M.; Postel-Vinay, S.; Angevin, E.; Ribrag, V.; Hollebecque, A.; Soria, J. C.; Robert, C.; Massard, C.; Marabelle, A.. Clin Cancer Res. 2018; : . doi:10.1158/1078-0432.CCR-18-0793Article
Oncostat